Literature DB >> 9600023

St. John's Wort (Hypericum perforatum): clinical effects on depression and other conditions.

A L Miller1.   

Abstract

St. John's Wort (Hypericum perforatum), a perennial flowering plant, has been used medicinally for thousands of years, and has most recently been identified as an effective treatment for mild to moderate depression. Clinical studies on the use of this plant for depression have utilized liquid tinctures and standardized solid extracts (0.3% hypericin--300 mg three times a day). Severe depression may also respond to this botanical, although it appears a larger dose is needed (600 mg solid extract three times a day). Hypericum has been favorably compared to numerous antidepressant drugs, the studies having revealed equivalent results and a much more favorable incidence of side effects. Studies have also demonstrated its efficacy in treating seasonal affective disorder. In vitro investigations of Hypericum show antiviral activity, although there is evidence these promising results might not occur in vivo. Traditional actions and uses include enhancement of wound healing, as well as anti-inflammatory and analgesic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600023

Source DB:  PubMed          Journal:  Altern Med Rev        ISSN: 1089-5159


  12 in total

1.  Adverse reactions to watch for in patients using herbal remedies.

Authors:  R Ko
Journal:  West J Med       Date:  1999-09

2.  Protective effects of St. John's wort in the hepatic ischemia/reperfusion injury in rats.

Authors:  Süleyman Atalay; Belkıs Soylu; Aslı Aykaç; Ayliz Velioğlu Öğünç; Şule Çetinel; Naziye Özkan; Can Erzik; Ahmet Özer Şehirli
Journal:  Turk J Surg       Date:  2018-08-28

3.  Plant-environment interactions: Accumulation of hypericin in dark glands of Hypericum perforatum.

Authors:  S M A Zobayed; F Afreen; E Goto; T Kozai
Journal:  Ann Bot       Date:  2006-08-04       Impact factor: 4.357

4.  Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson's Disease.

Authors:  Zahra Kiasalari; Tourandokht Baluchnejadmojarad; Mehrdad Roghani
Journal:  Cell Mol Neurobiol       Date:  2015-06-29       Impact factor: 5.046

5.  The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Authors:  Sarah Canning; Mitch Waterman; Nic Orsi; Julie Ayres; Nigel Simpson; Louise Dye
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

6.  The effect of Hypericum perforatum (St. John's Wort) on experimental colitis in rat.

Authors:  Turhan Dost; Hakan Ozkayran; Filiz Gokalp; Cigdem Yenisey; Mustafa Birincioglu
Journal:  Dig Dis Sci       Date:  2008-08-27       Impact factor: 3.199

7.  Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice.

Authors:  Rosalia Crupi; Emanuela Mazzon; Angela Marino; Giuseppina La Spada; Placido Bramanti; Fortunato Battaglia; Salvatore Cuzzocrea; Edoardo Spina
Journal:  BMC Complement Altern Med       Date:  2011-01-27       Impact factor: 3.659

8.  Local knowledge about sustainable harvesting and availability of wild medicinal plant species in Lemnos island, Greece.

Authors:  Dimitrios Papageorgiou; Penelope J Bebeli; Maria Panitsa; Christoph Schunko
Journal:  J Ethnobiol Ethnomed       Date:  2020-06-19       Impact factor: 2.733

9.  Evaluation of Motor Coordination and Antidepressant Activities of Cinnamomum osmophloeum ct. Linalool Leaf Oil in Rodent Model.

Authors:  Hui-Ting Chang; Mei-Ling Chang; Yen-Ting Chen; Shang-Tzen Chang; Fu-Lan Hsu; Chia-Chen Wu; Cheng-Kuen Ho
Journal:  Molecules       Date:  2021-05-19       Impact factor: 4.411

10.  Remarkable rutin-rich Hypericum capitatum extract exhibits anti-inflammatory effects on turpentine oil-induced inflammation in rats.

Authors:  Anca D Farcas; Augustin C Mot; Cezara Zagrean-Tuza; Madalina Ticolea; Bogdan Sevastre; Muhittin Kulak; Radu Silaghi-Dumitrescu; Alina Parvu
Journal:  BMC Complement Altern Med       Date:  2019-10-29       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.